Urolithin A activates mitophagy through PINK1/Parkin pathway and AMPK/ULK1 signaling. Specifically: (1) it stabilizes PINK1 on the outer mitochondrial membrane of damaged mitochondria (PINK1 normally degrades on healthy mitochondria); (2) stabilized PINK1 recruits Parkin (E3 ubiquitin ligase), which ubiquitinates the damaged mitochondrion; (3) ubiquitinated mitochondria are recognized by autophagy receptors (p62, OPTN), engulfed in autophagosomes, and degraded. This selective removal of damaged mitochondria allows the cell to replace them with new, functional mitochondria (via mitochondrial biogenesis) — improving overall cellular energy production. This is the "quality control" mechanism for the cell's power plants.
No critical interactions identified.
No significant drug interactions documented.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.